Breaking News, Collaborations & Alliances

Caprion-HistoGeneX Partners with Viroclinics-DDL

Will offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development.

By: Contract Pharma

Contract Pharma Staff

Caprion–HistoGeneX and Viroclinics–DDL have announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target infectious diseases including COVID-19.   This partnership brings together the leadership of two prominent contract research organizations serving the pharmaceutical and biotechnology community with specialized assays and technologies relevant to clinical and preclinical studies aimed a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters